ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,346 | +47.0% | 25,600 | +93.9% | 0.00% | – |
| Q1 2023 | $5,676 | -77.0% | 13,200 | -71.6% | 0.00% | – |
| Q4 2022 | $24,630 | -80.3% | 46,471 | -72.9% | 0.00% | – |
| Q3 2022 | $125,000 | +115.5% | 171,335 | +238.6% | 0.00% | – |
| Q2 2022 | $58,000 | -66.3% | 50,600 | -39.7% | 0.00% | – |
| Q1 2022 | $172,000 | -72.5% | 83,865 | -61.3% | 0.00% | – |
| Q4 2021 | $625,000 | -28.6% | 216,896 | +5.1% | 0.00% | – |
| Q3 2021 | $875,000 | -30.4% | 206,343 | -13.1% | 0.00% | – |
| Q2 2021 | $1,258,000 | -39.7% | 237,582 | -47.1% | 0.00% | – |
| Q1 2021 | $2,087,000 | +228.7% | 448,870 | +133.3% | 0.00% | – |
| Q4 2020 | $635,000 | +20.0% | 192,416 | +20.4% | 0.00% | – |
| Q3 2020 | $529,000 | -62.7% | 159,782 | -62.1% | 0.00% | – |
| Q2 2020 | $1,420,000 | +261.3% | 421,373 | +310.4% | 0.00% | – |
| Q1 2020 | $393,000 | -53.5% | 102,666 | -26.7% | 0.00% | – |
| Q4 2019 | $846,000 | -23.6% | 139,971 | -4.4% | 0.00% | – |
| Q3 2019 | $1,107,000 | -32.9% | 146,400 | +20.2% | 0.00% | – |
| Q2 2019 | $1,650,000 | +195.2% | 121,800 | +18.1% | 0.00% | – |
| Q1 2019 | $559,000 | +75.2% | 103,100 | -4.2% | 0.00% | – |
| Q4 2018 | $319,000 | -80.6% | 107,600 | -46.5% | 0.00% | – |
| Q3 2018 | $1,642,000 | +22.1% | 201,278 | +45.7% | 0.00% | -100.0% |
| Q2 2018 | $1,345,000 | +132.7% | 138,100 | +107.7% | 0.00% | – |
| Q1 2018 | $578,000 | -13.3% | 66,500 | +24.8% | 0.00% | – |
| Q4 2017 | $667,000 | -53.6% | 53,300 | -69.0% | 0.00% | -100.0% |
| Q3 2017 | $1,437,000 | -85.4% | 171,900 | -70.3% | 0.00% | -88.9% |
| Q2 2017 | $9,815,000 | +21.7% | 578,331 | +44.1% | 0.01% | +28.6% |
| Q1 2017 | $8,068,000 | +4510.3% | 401,427 | +3484.2% | 0.01% | – |
| Q4 2016 | $175,000 | -62.4% | 11,200 | -68.5% | 0.00% | – |
| Q3 2016 | $465,000 | – | 35,577 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 4,898,927 | $6,246,132 | 0.70% |
| Yakira Capital Management, Inc. | 620,019 | $790,524 | 0.22% |
| Crystalline Management Inc. | 230,817 | $294,292 | 0.21% |
| DELTEC ASSET MANAGEMENT LLC | 475,000 | $605,625 | 0.14% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,283,979 | $2,912,073 | 0.12% |
| PenderFund Capital Management Ltd. | 123,444 | $213 | 0.06% |
| FIFTH LANE CAPITAL, LP | 100,000 | $127,000 | 0.04% |
| CSS LLC/IL | 476,831 | $607,960 | 0.04% |
| Penserra Capital Management LLC | 220,858 | $280 | 0.01% |
| King Wealth Management Group | 16,000 | $20 | 0.00% |